Details for Patent: 11,590,088
✉ Email this page to a colleague
Which drugs does patent 11,590,088 protect, and when does it expire?
Patent 11,590,088 protects VTAMA and is included in one NDA.
Drugs Protected by US Patent 11,590,088
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,590,088 | ⤷ Subscribe | TOPICAL TREATMENT OF PLAQUE PSORIASIS IN ADULTS | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |